» Articles » PMID: 35284119

is Associated with Metastasis and Glutathione/glycosphingolipid Metabolism in Colon Adenocarcinoma

Overview
Date 2022 Mar 14
PMID 35284119
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metastasis is the major cause of colon adenocarcinoma (COAD) mortality. Increasing studies demonstrated that the epigenetics and downstream expression change of pivotal genes may act as a major role in promoting COAD progression and metastasis. Therefore, identifying the dysregulation of key genes associating with COAD metastasis may provide a new strategy for the discovery of potential treatment targets.

Methods: This study included a single-cell RNA sequencing profile consisting of 17,469 tumor cells derived from 23 samples, and 326 COADs available from The Cancer Genome Atlas (TCGA), etc. The study was performed using comparative analysis to characterize the role of in COAD metastasis and progression.

Results: This study revealed that the mRNA level of Chromebox homolog 3 () in the metastatic COAD was significantly higher than that of the primary COAD and normal colon tissues (Wilcoxon's rank-sum test, P<0.05). Activation of was involved in regulating an interaction network consisting of , , and , etc., which may subsequently participate in glutathione metabolism. Besides, also exhibited a negative correlation with glycosphingolipid metabolism, which may associate with the regulation of CBX3 on DNA methylation. Clinical data analysis demonstrated that patients with high mRNA levels showed a nearly 2-fold shorter overall survival time than the control group (hazard ratio =1.59; likelihood ratio test, P=0.04).

Conclusions: Our study demonstrated that overexpression is associated with COAD metastasis. downstream regulation network involves in TCP1 complex, LSM family, and glutathione metabolism, which may provide a potential target for suppressing tumor metastasis.

Citing Articles

Integrating Bulk RNA and Single-Cell RNA Sequencing Identifies and Validates Lactylation-Related Signatures for Intervertebral Disc Degeneration.

Shi Y, Li F, Lin W, Han L, Wang J, Yan C J Cell Mol Med. 2024; 28(23):e70262.

PMID: 39636180 PMC: 11619158. DOI: 10.1111/jcmm.70262.


Serine related gene CCT6A promotes metastasis of hepatocellular carcinoma via interacting with RPS3.

Cui H, Jiang L, Zhou Y, Zhou Y, Li F, Zhang Z Funct Integr Genomics. 2024; 24(6):225.

PMID: 39630318 DOI: 10.1007/s10142-024-01497-7.


Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer.

Wahab M, Del Gaudio N, Gargiulo B, Quagliariello V, Maurea N, Nebbioso A Cancers (Basel). 2024; 16(17).

PMID: 39272883 PMC: 11394081. DOI: 10.3390/cancers16173026.


Sm-like 5 knockdown inhibits proliferation and promotes apoptosis of colon cancer cells by upregulating p53, CDKN1A and TNFRSF10B.

Mo C, Deng X, Ma R, Zhu K, Shi L, Li K World J Gastrointest Oncol. 2024; 16(6):2716-2726.

PMID: 38994171 PMC: 11236259. DOI: 10.4251/wjgo.v16.i6.2716.


CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity.

Chen J, Lin Y, Zheng S, Chen Q, Tang S, Zhong X J Transl Med. 2023; 21(1):600.

PMID: 37674204 PMC: 10483741. DOI: 10.1186/s12967-023-04478-9.

References
1.
Chang S, Lai Y, Chen Y, Wang N, Wang W, Lai J . CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer. Asia Pac J Clin Oncol. 2017; 14(5):e283-e288. DOI: 10.1111/ajco.12820. View

2.
West N, McCuaig S, Franchini F, Powrie F . Emerging cytokine networks in colorectal cancer. Nat Rev Immunol. 2015; 15(10):615-29. DOI: 10.1038/nri3896. View

3.
Mariani F, Sena P, Roncucci L . Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol. 2014; 20(29):9716-31. PMC: 4123361. DOI: 10.3748/wjg.v20.i29.9716. View

4.
Stange D, Engel F, Longerich T, Koo B, Koch M, Delhomme N . Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut. 2010; 59(9):1236-44. DOI: 10.1136/gut.2009.195701. View

5.
Vera R, Gonzalez-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo J . Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM. Clin Transl Oncol. 2019; 22(5):647-662. DOI: 10.1007/s12094-019-02182-z. View